Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma.

Abstract

During the course of multiple myeloma (MM), new monoclonal proteins of an isotype distinct from the original clone, referred to as secondary monoclonal gammopathy of undetermined significance (MGUS), have been described. We report on the frequency, characteristics, and outcome of secondary MGUS. Of the 1942 patients with MM, 128 (6.6%) developed a secondary… (More)
DOI: 10.1182/blood-2011-04-349175

Topics

1 Figure or Table

Cite this paper

@article{Wadhera2011IncidenceCC, title={Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma.}, author={Rishi K. Wadhera and Robert Arthur Kyle and Dirk Russell Larson and Angela Dispenzieri and Shaji K Kumar and Hillard M Lazarus and S Vincent Rajkumar}, journal={Blood}, year={2011}, volume={118 11}, pages={2985-7} }